Lixiang Xue

5.1k total citations · 3 hit papers
137 papers, 3.3k citations indexed

About

Lixiang Xue is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Lixiang Xue has authored 137 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 38 papers in Cancer Research and 30 papers in Immunology. Recurrent topics in Lixiang Xue's work include Epigenetics and DNA Methylation (22 papers), RNA modifications and cancer (20 papers) and Cancer-related molecular mechanisms research (16 papers). Lixiang Xue is often cited by papers focused on Epigenetics and DNA Methylation (22 papers), RNA modifications and cancer (20 papers) and Cancer-related molecular mechanisms research (16 papers). Lixiang Xue collaborates with scholars based in China, United States and Hong Kong. Lixiang Xue's co-authors include Junjie Wang, Zelian Qin, Hao Wang, Chunxiao Li, Tanjun Tong, Ping Jiang, Shuhua Wei, Xiaofei Xu, Hongyan Guo and Yueqing Gong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Lixiang Xue

122 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage

2018 410 citations Junjie Wang, Lixiang Xue et al. profile →
Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

2021 232 citations Chunxiao Li, Xiaofei Xu et al. Journal for ImmunoTherapy of Cancer profile →
Hydrogen sulfide alleviates particulate matter-induced emphysema and airway inflammation by suppressing ferroptosis

2022 132 citations Lixiang Xue, Shaohua Ma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lixiang Xue China	32	2.0k	1.0k	670	557	372	137	3.3k
Guoxiong Xu China	31	1.8k 0.9×	905 0.9×	391 0.6×	561 1.0×	369 1.0×	145	3.5k
Alexander Weidemann Germany	31	1.8k 0.9×	1.8k 1.7×	785 1.2×	478 0.9×	401 1.1×	46	4.2k
Min Feng China	29	1.6k 0.8×	887 0.9×	391 0.6×	626 1.1×	266 0.7×	112	2.9k
Weina Chen United States	35	1.7k 0.9×	620 0.6×	567 0.8×	801 1.4×	190 0.5×	221	4.2k
Ganapati H. Mahabeleshwar United States	31	2.1k 1.1×	768 0.8×	998 1.5×	446 0.8×	210 0.6×	46	3.5k
Anthony W. Ashton United States	35	1.8k 0.9×	575 0.6×	507 0.8×	498 0.9×	270 0.7×	87	3.7k
Huifang Liang China	35	2.3k 1.1×	1.2k 1.2×	585 0.9×	792 1.4×	443 1.2×	172	3.9k
Ella Ioffe United States	16	2.3k 1.1×	643 0.6×	410 0.6×	768 1.4×	340 0.9×	24	3.6k

Countries citing papers authored by Lixiang Xue

Since Specialization

Citations

This map shows the geographic impact of Lixiang Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixiang Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixiang Xue more than expected).

Fields of papers citing papers by Lixiang Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixiang Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixiang Xue. The network helps show where Lixiang Xue may publish in the future.

Co-authorship network of co-authors of Lixiang Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Lixiang Xue. A scholar is included among the top collaborators of Lixiang Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixiang Xue. Lixiang Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Zhengyang, Yunyun Guo, Xiao Huo, et al.. (2025). Oleic acid activates TGFβ-Smad3 signaling to promote ovarian cancer progression. Journal of Ovarian Research. 18(1). 180–180.

Xue, Lixiang, et al.. (2025). Lipid-Metabolism-Related Gene Signature Predicts Prognosis and Immune Microenvironment Alterations in Endometrial Cancer. Biomedicines. 13(5). 1050–1050.

Xue, Lixiang, et al.. (2025). Mercury Pollution in a Coastal City of Northern China Driven by Temperature Re-Emission, Coal Combustion, and Port Activities. Atmosphere. 16(10). 1121–1121.

Qiang, Guangliang, Guozhou Zhang, Jinhui Feng, et al.. (2025). The novel thioredoxin reductase inhibitor butaselen suppresses lung cancer by inducing oxidative stress. Redox Report. 30(1). 2588086–2588086.

Li, Bing, et al.. (2025). Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development, and precision medicine. Protein & Cell. 1 indexed citations

Chen, Zhongrong, Zhi Q. Yao, Mengfan Wu, et al.. (2025). Epigenetic reprogramming via EZH2 inhibition rescues fibroadipose pathogenesis in secondary lymphedema through activating PPARγ signaling. Journal of Orthopaedic Translation. 55. 309–322.

Wang, Ying, Guoqing Han, Jin Yang, Lixiang Xue, & Yahong Chen. (2025). Hydrogen sulfide attenuates PM2.5-induced COPD by inhibiting cellular senescence via the Klotho/Parkin-mediated mitophagy signaling pathway. Ecotoxicology and Environmental Safety. 293. 117987–117987. 4 indexed citations

Chen, Yong, Haojie Jin, Baohui Xu, et al.. (2024). Systemic Characterization of the Gut Microbiota Profile after Single Mild Ischemic Stroke and Recurrent Stroke in Mice. Biomedicines. 12(1). 195–195. 3 indexed citations

Huang, Jiaqi, Qianqian Yin, Yuqing Wang, et al.. (2024). EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal Cancer. Advanced Science. 11(23). e2308045–e2308045. 20 indexed citations

10.

Han, Zheng, Mingchen Liu, Shi Shu, et al.. (2024). MAP4K4 and WT1 mediate SOX6‐induced cellular senescence by synergistically activating the ATF2–TGFβ2–Smad2/3 signaling pathway in cervical cancer. Molecular Oncology. 18(5). 1327–1346. 10 indexed citations

11.

Chang, Chun, et al.. (2023). Association between Changes in Plasma Metabolism and Clinical Outcomes of Sepsis. Emergency Medicine International. 2023. 1–11. 3 indexed citations

12.

Chen, Yi‐Fan, et al.. (2023). Integrative analysis of DNA methylomes reveals novel cell-free biomarkers in lung adenocarcinoma. Frontiers in Genetics. 14. 1175784–1175784. 2 indexed citations

13.

Liu, Tong, et al.. (2022). Glutamine Transporter SLC1A5 Regulates Ionizing Radiation‐Derived Oxidative Damage and Ferroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 3403009–3403009. 20 indexed citations

14.

Li, Chunxiao, Xiaofei Xu, Shuhua Wei, et al.. (2021). Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. Journal for ImmunoTherapy of Cancer. 9(1). e001341–e001341. 232 indexed citations breakdown →

15.

Qiu, Bin, Hao Wang, Ping Jiang, et al.. (2021). Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy. Cancers. 13(14). 3493–3493. 8 indexed citations

16.

Bi, Xueyun, Pengbo Lou, Yongli Song, et al.. (2021). Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3–Mmp9 pathway. Oncogene. 40(29). 4832–4845. 18 indexed citations

17.

Xue, Lixiang, et al.. (2017). miRNA-31 Increases Radiosensitivity Through Targeting a Novel Target STK40 in Colorectal Cancer Cell Lines. International Journal of Radiation Oncology*Biology*Physics. 99(2). E629–E629. 1 indexed citations

18.

Gao, Shu-Bin, Bin Xu, Yue Zhao, et al.. (2014). EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma. Molecular Cancer Research. 12(10). 1388–1397. 61 indexed citations

19.

Wang, Xiao, Yujing Bi, Bo Shen, et al.. (2014). Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide. Journal of Leukocyte Biology. 96(5). 675–684. 44 indexed citations

20.

Xue, Lixiang, Chunxia Yao, Shanfeng Zhang, et al.. (2013). Insulin induces C2C12 cell proliferation and apoptosis through regulation of cyclin D1 and BAD expression. Journal of Cellular Biochemistry. 114(12). 2708–2717. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact